Project
Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe) (SRP48)
Researchers
- Karin Vanderkerken (Promoter)Duration: 1 Oct 2019 → Today
- Karin Vanderkerken (Promoter)Duration: 1 Oct 2019 → Today
- Karin Vanderkerken (Promoter)Duration: 1 Oct 2019 → Today
- Kris Thielemans (Promoter)Duration: 1 Nov 2017 → 30 Sep 2019
- Kris Thielemans (Promoter)
Immunomodulation in Chronic Inflammatory Diseases
Duration: 1 Nov 2017 → 30 Sep 2019 - Kris Thielemans (Promoter)
Laboratory of Molecullar and Cellular Therapy
Duration: 1 Nov 2017 → 30 Sep 2019 - Kris Thielemans (Promoter)Duration: 1 Nov 2017 → 30 Sep 2019
- K Breckpot (Co-promoter)Duration: 1 Nov 2017 → Today
- K Breckpot (Co-promoter)
Laboratory of Molecullar and Cellular Therapy
Duration: 1 Nov 2017 → Today - Karin Vanderkerken (Co-promoter)Duration: 1 Nov 2017 → 30 Sep 2019
- Karin Vanderkerken (Co-promoter)Duration: 1 Nov 2017 → 30 Sep 2019
Project partners
- Immunomodulation in Chronic Inflammatory Diseases (Research group)From1 Nov 2017 → 30 Sep 2019
- Laboratory of Molecullar and Cellular Therapy (Research group)From1 Nov 2017 → 30 Sep 2019
- R&D centraal (Administrative office)From1 Oct 2019 → Today
- Basic (bio-) Medical Sciences (Department)From1 Oct 2019 → Today
- Hematology (Research group)From1 Oct 2019 → Today
- Physiology (Department)
Project owner
Funding
1 - 1 of 1 results
- Funding: University - Project driven research(Principal funding)
Funding party: Universities
Policy level funding: Flemish
Publications
- Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells(2017)
Authors: Nathan De Beule, Eline Menu, Mathieu Jm Bertrand, Mérédis Favreau, Elke De Bruyne, Ken Maes, Kim De Veirman, Magdalena Radwanska, Afshin Samali, Stefan Magez, et al.
- Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade(2021)
Authors: R M Awad, Q Lecocq, Katty Zeven, T Ertveldt, L De Beck, Hannelore Ceuppens, Katrijn Broos, Y De Vlaeminck, Cleo Goyvaerts, Magali Verdonck, et al.
- Theranostics in immuno-oncology using nanobody derivatives(2019)
Authors: Q Lecocq, Y De Vlaeminck, Heleen Hanssens, Matthias D'Huyvetter, G Raes, Cleo Goyvaerts, M Keyaerts, Nick Devoogdt, K Breckpot
- Noninvasive imaging of the PD-1:PD-L1 immune checkpoint: Embracing nuclear medicine for the benefit of personalized immunotherapy(2018)
Authors: Katrijn Broos, Q Lecocq, G Raes, Nick Devoogdt, M Keyaerts, K Breckpot
- Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer(2022)
Authors: Hanne Locy, Stefaan Verhulst, Wilfried Cools, Wim Waelput, Stefanie Brock, Louise Cras, Ann Schiettecatte, Jan Jonckheere, Leo A van Grunsven, Marian Vanhoeij, et al.
- Checkpoint inhibition in the treatment of multiple myeloma(2018)
Authors: Koen Venken, Mérédis Favreau, Djoere Gaublomme, Eline Menu, Karin Vanderkerken, Dirk Elewaut
- Perforin and Granzyme B Expressed by Murine Myeloid-Derived Suppressor Cells: A Study on Their Role in Outgrowth of Cancer Cells(2019)
Authors: Inès Dufait, Julian Pardo, David Escors, Y De Vlaeminck, H. Jiang, M Keyaerts, Mark De Ridder, K Breckpot
- Broadening the Message(2019)
Authors: Rein Verbeke, Ine Lentacker, K Breckpot, Jonas Janssens, Serge Van Calenbergh, Stefaan C De Smedt, Heleen Dewitte
- Correction(2018)
Authors: Nathan De Beule, Eline Menu, Mathieu J. M. Bertrand, Mérédis Favreau, Elke De Bruyne, Ken Maes, Kim De Veirman, Magdalena Radwanska, Afshin Samali, Stefan Magez, et al.
- Anti-human PD-L1 Nanobody for Immuno-PET Imaging(2020)
Authors: Jessica Bridoux, Katrijn Broos, Q Lecocq, P Debie, Charlotte Martin, Steven Ballet, G Raes, Sara Neyt, , K Breckpot, et al.